Robert Andrew Douglas - 13 Nov 2023 Form 4 Insider Report for RESMED INC (RMD)

Role
President and COO
Signature
Robert Douglas, President and Chief Operating Officer, ResMed Inc.
Issuer symbol
RMD
Transactions as of
13 Nov 2023
Net transactions value
-$244,735
Form type
4
Filing time
15 Nov 2023, 20:23:15 UTC
Previous filing
16 Aug 2023
Next filing
20 Nov 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RMD ResMed Common Stock Tax liability $135,636 -945 -5.6% $143.60 15,985 13 Nov 2023 Direct F1
transaction RMD ResMed Common Stock Tax liability $109,099 -760 -4.8% $143.60 15,224 13 Nov 2023 Direct F2, F3
holding RMD ResMed Common Stock 250,526 13 Nov 2023 Douglas Family Trust
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Disposition to issuer for tax withholding on vesting of Restricted Stock Units granted on 11/19/2020.
F2 Disposition to issuer for tax withholding on vesting of Restricted Stock Units granted on 11/18/2021.
F3 Includes 54.45 shares of ResMed stock purchased on October 31, 2023, through the ResMed Employee Stock Purchase Plan.